Preclinical Toxicology Study Design Consultant

Toxicologists and non-clinical programme leads at pharmaceutical companies planning the preclinical safety package for a new drug candidate use this agent to design a study battery that supports the intended clinical indication, route, and patient population under ICH M3(R2) and S-series guidelines.